Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sulphur
- Development stage
- Phase 4
- Administration
- Oral
01
Overview
Sulphur is a homoeopathic medicine that has been evaluated for its usefulness in managing Schizophrenia and Atopic Dermatitis. In homoeopathic practice, it is typically prescribed in various potencies, such as 30C, after repertorization and consultation of Materia Medica. Studies have suggested its positive role in improving symptoms in patients with these conditions.
- Brand names
- Prosacea
- Other names
- Prosacea medicated gelsulphur 1x topical gelsulphur1x topical gelsulphur-1x topical gel
Beyond the preview
Go deeper on Sulphur.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sulphur.